Xydalba – A full treatment course in one 30 minute infusion

Xydalba is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults1.

The content of this website has been developed for UK healthcare professionals only.

Xydalba is contraindicated in patients hypersensitive to the active substance or to any of the excipients (mannitol {E421}, lactose monohydrate, hydrochloric acid and sodium hydroxide {pH adjusters}).1

Prescribing-only medicine.

1. Xydalba SmPC
Item code: XYUK05102020WS

Date of preparation: October 2020

Laura MacLachlan explains the benefits of Xydalba